9130008F23Rik Inhibitors
The chemical class termed 9130008F23Rik Inhibitors comprises a diverse set of compounds targeting specific signaling pathways and cellular processes associated with the protein. Staurosporine, a broad-spectrum kinase inhibitor, impedes phosphorylation cascades. Wortmannin and LY294002, both PI3K inhibitors, disrupt the PI3K/Akt pathway, indirectly impacting 9130008F23Rik. SB-216763 and U0126, targeting GSK-3 and MEK1/2, respectively, modulate the Wnt and MAPK/ERK pathways, influencing cellular events linked to the protein. SP600125, a JNK inhibitor, disrupts the MAPK signaling network, contributing to indirect inhibition. SP2509, PD98059, and GSK-650394 target BRD4, MEK1, and p38 MAPK, respectively, affecting epigenetic regulation and MAPK pathways associated with 9130008F23Rik. A769662, an AMPK activator, modulates cellular energy balance, indirectly influencing pathways linked to the protein. BAY 11-7082 inhibits NF-κB activation, impacting inflammatory responses and pathways associated with 9130008F23Rik. PP2, a Src family kinase inhibitor, disrupts tyrosine kinase activity, providing indirect inhibition of events associated with the protein. Collectively, these compounds form a class of inhibitors with diverse mechanisms, collectively influencing the cellular processes involving 9130008F23Rik.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor that targets a broad range of kinases, including serine/threonine and tyrosine kinases, hindering phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor, disrupting the PI3K signaling pathway. This indirectly inhibits 9130008F23Rik by interfering with downstream cascades. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB-216763 is a glycogen synthase kinase 3 (GSK-3) inhibitor, impacting the Wnt signaling pathway. Inhibition of GSK-3 indirectly modulates pathways involving 9130008F23Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), influencing MAPK signaling. This indirectly affects 9130008F23Rik, as JNK is part of a signaling network interconnected with the protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is another PI3K inhibitor, obstructing the PI3K/Akt pathway. Its interference disrupts downstream events linked to 9130008F23Rik, providing an indirect inhibitory effect. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1/2, key components of the MAPK/ERK pathway. By disrupting this pathway, U0126 indirectly influences the cellular processes involving 9130008F23Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK1, an upstream regulator of ERK1/2. Its action disrupts the MAPK/ERK pathway, leading to indirect inhibition of cellular processes associated with 9130008F23Rik. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $183.00 $754.00 | 8 | |
GSK-650394 is an inhibitor of p38 MAPK, disrupting the p38 MAPK signaling pathway. The inhibition of p38 MAPK indirectly influences cellular events involving 9130008F23Rik. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
A769662 is an AMP-activated protein kinase (AMPK) activator, modulating cellular energy balance. By impacting AMPK, A769662 indirectly affects pathways linked to 9130008F23Rik. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation, a key transcription factor involved in inflammatory responses. Its action interferes with pathways associated with 9130008F23Rik, providing indirect inhibition. | ||||||